null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Anti-ASIC1 Antibody [N271/44 (Formerly sold as S271-44)]

SKU STMA00132
Antibody Type Monoclonal
Applications WB
Applications IHC
Applications ICC/IF
Reactivity Human
Reactivity Mouse
Reactivity Rat
Host Species Mouse
Isotype IgG1
€647
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

ASIC1 Antibody [N271/44 (Formerly sold as S271-44)]

ASIC1 Antibody [N271/44 (Formerly sold as S271-44)] is a mouse monoclonal antibody directed against ASIC1, offered by Assay Genie for research applications. Reported applications include WB, IHC and ICC/IF. Reported reactivity: Human, Mouse and Rat. Supplied as IgG1, purified by Protein G.

Acid-sensing ion channel 1 (ASIC1), also known as ASIC1a, ACCN2, and BNAC2, is a proton-gated cation channel highly expressed in the central nervous system. It plays a critical role in detecting extracellular pH changes and mediating neuronal excitability in response to acidosis. ASIC1 is encoded as a 4.3-kb transcript and is prominently localized in the rat brain, particularly in the olfactory bulb, cerebral cortex, hippocampus, habenula, basolateral amygdala, and cerebellum. Functionally, ASIC1 contributes to synaptic plasticity, learning, and memory, and is involved in the modulation of fear and anxiety-related behaviors. Its activation by protons leads to sodium influx, influencing neuronal firing and excitotoxicity under pathological conditions. In the context of neurodegenerative disease, ASIC1 has gained attention for its role in ischemic brain injury, traumatic brain injury, and chronic neuroinflammation. ASIC1a, the predominant isoform in neurons, is permeable to calcium and has been implicated in acidosis-induced neuronal death—a common feature in stroke and neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Given its dual role in physiological signaling and pathological damage, ASIC1 is emerging as a promising therapeutic target. Inhibiting ASIC1 activity may offer neuroprotection by reducing calcium overload and excitotoxicity in vulnerable brain regions. Understanding the spatial expression and functional dynamics of ASIC1 is essential for advancing therapeutic strategies in neurodegenerative disease research. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose